Clinical Trials Logo

Clinical Trial Summary

Objective(s) of the trial: Better understand the interaction between kinesiophobia and motor control. Main objective: To measure the influence of induced kinesiophobia on functional connectivity between the posterior parieto-occipital region and the primary motor cortex in healthy subjects during a pointing task. Secondary objectives: The secondary objectives will be 1) to verify the excitatory influence of pIPS stimulation on the excitability of M1 at rest and 2) to establish whether there is a correlation between functional connectivity and the level of kinesiophobia ( as measured by the Tampa Scale)


Clinical Trial Description

This work will focus on a population of 30 healthy volunteer subjects who will be recruited via a posting within the Faculty of Sports Sciences of Lille, the University of Littoral Côte d'Opale and Eurasport. Compensation of 50 euros per subject is provided for participation in the study. All these criteria will be reviewed during the visit to the clinical neurophysiology department during which each subject will be seen in an interview with a neurologist (Pr. Arnaud Delval, PU-PH of the clinical neurophysiology department of Lille University Hospital) before the start of the investigations. Explorations may be stopped at any time upon simple request from the participant. Each subject may leave the study by decision of the competent administrative authority, the promoter and the coordinating investigator but also by decision of a co-investigator or by decision of the interested party himself in accordance with the regulations and as mentioned in the consent. The data recorded in subjects who decide to leave the study will be partial and not exploitable, it will therefore be destroyed. In this study, the impact of induced kinesiophobia on the functional connectivity between the PPC (posterior parietal cortex) and M1 (primary motor cortex) in healthy subjects during the preparatory phase of a pointing task will be assessed. Participants will undergo three transcranial magnetic stimulation (TMS) sessions. The first session will be designed to define the optimal inter-stimulus intervals (ISIs) between both paired-pulses, with the conditioned stimulus (CS) applied to the PPC and the test stimulus (TS) applied to the M1. The second session will aim to define the optimal delay between the pointing start command (indicated by light signals) and the TS pulse over M1. The last session will determine whether a pointing start command related to a threat (indicated by a red light signal) has a different impact than a neutral pointing start command (indicated by a green light signal) on the functional connectivity between the PPC and M1. To assess the personality of participants concerning kinesiophobia and fear-avoidance, participants will respond to two online questionnaires using RedCap, the Research Electronic Data Capture system. The questionnaires include the Tampa Scale for Kinesiophobia French version (TSK-CF) and the Fear-Avoidance Components Scale French version (FACS-Fr). Following the completion of the questionnaires, participants will be seated comfortably in a reclining chair, with their feet resting on a footrest. The right arm will rest on a height-adjustable shelf. Electrodes for collecting electromyography (EMG) activity will be placed on the skin over the first dorsal interosseous (FDI) muscles of the right hand. This specific muscle is chosen due to its involvement in pointing tasks, and the cortical area controlling it is relatively large and easy to locate. The EMG electrodes will be connected to a recording system composed of a Digitimer D360 amplifier (UK) and a 1401 Micro MKII acquisition interface (Cambridge Electronic Design, Cambridge, UK). The data will be stored on a computer for offline analysis using Signal© software (Cambridge Electronic Design, Cambridge, UK). Two figure-of-eight coils will be employed to induce a test stimulus (TS) and conditioning stimulus (CS). The first coil, with a 50 mm monophasic pulse, utilized for the test stimulus (TS), will be held tangentially to the skull over the left hemisphere's M1, which controls the right FDI muscle. It will be oriented at a 45° angle in the medial sagittal plane to induce an electric current oriented in the posterior to anterior direction. The test stimulus will be delivered at an intensity allowing a motor evoked potential (MEP) of 1mV to be obtained in a control situation over the spot generating the greatest MEP of the FDI muscle. The second coil, with an 80 mm monophasic pulse, used for the conditioning stimulus (CS), will be positioned over the P3 spot of the 10/20 system, corresponding to the posterior region of the intraparietal sulcus (pIPS) of the left hemisphere. It will be held tangentially to the scalp along a parasagittal axis to enable proper placement of both coils on the same hemisphere. The conditioning stimulus will be applied on the pIPS at an intensity of 90% of the motor threshold (RMT), which corresponds to the smallest stimulation intensity that evokes 5 small responses (≥50 mV peak to peak) on the FDI muscle during a series of 10 stimulations in the subject at rest. In this double-pulse TMS method, both coils used will be connected to stimulators, with the first coil (TS) connected to a Magstim stimulator (Whitland, UK) and the second coil (CS) connected to a Mag&More stimulator (Munich, Germany). In the forthcoming experimental setup, investigators will arrange an environment in front of participants, incorporating four tactile light sensors (as shown in Fig. 1). The first sensor, white in color, will be positioned on a horizontal plane approximately thirty centimeters from the subject's bust, serving as the starting point for pointing tasks in sessions 2 and 3. The second sensor, also white, will be situated on an inclined plane (45°) facing the subjects, serving as the arrival point for pointing tasks in sessions 2 and 3. Adjacent to this second tactile light sensor on the inclined plane, a green light sensor on the left and a red one on the right will be placed to provide indications for the pointing task in session 3. During the first TMS session, the focus will be on determining customized inter-stimulus intervals at rest. Building on a previous TMS paired pulse study that concentrated on the interaction between the PPC and ipsilateral M1 (25), various inter-stimulus intervals (ISIs) between CS and TS will be tested at 3, 4, 5, 6, 7, and 8 ms. Seven conditions will be randomly intermingled, including TS alone (MEP) and CS+TS (conditioned MEP for each of the six different ISIs). Eight responses will be collected for the test stimulus alone and eight responses for conditioned MEPs at each ISI. The test stimulus will be delivered at an intensity to evoke an MEP of 1mV, and the conditioning stimulus will be delivered at an intensity of 90% of the resting motor threshold (RMT). Single pulses or doublets of stimulation will be spaced at an interval varying between 8 and 12 seconds. Measurements will be taken on each individual trial, and the mean peak-to-peak amplitude of the conditioned MEP will be expressed as a percentage of the mean peak-to-peak amplitude of the unconditioned test pulse. For the subsequent sessions, the customized optimal parameters for each participant, determined in the first session, will be used to best activate PPC-M1 interplay. In the upcoming second TMS session, the focus will be on determining a customized delay after light signals. Participants will be instructed to wait for the first white horizontal tactile light sensor to turn on, signaling them to place their right index finger on it. After a few seconds, the green light will turn on, indicating that participants should prepare to lift their index finger to point at the second white tactile light sensor located on an inclined plane. Once the latter lights up white, participants are instructed to start the pointing task to touch it, turn it off, and then rest their right arm on the height-adjustable shelf, waiting for the first white horizontal tactile light sensor to turn on again for the next trial. Building on a previous study focused on PPC-M1 functional connectivity during the early phase of movement planning, transcranial magnetic stimulation (TMS) will be delivered over M1 of the left hemisphere at different delays (50, 75, 100, and 125 ms) after the second white tactile light sensor located on an inclined plane turns on. Investigators will use the following parameters to best activate PPC-M1 interplay: the test stimulus (TS) delivered at an intensity to evoke a motor evoked potential (MEP) of 1mV, and in half of the experiments, a conditioning stimulus (CS) applied to the ipsilateral PPC with an intensity set at 90% of the resting motor threshold (RMT), using the customized optimal inter-stimulus interval (ISI) for each participant. Single pulses or doublets of stimulation will be spaced at an interval varying between 8 and 12 seconds. To investigate the influence of kinesiophobia on PPC-M1 connectivity at rest, a fake electrode will be placed at the right Erb's point near the collarbone for each participant. Participants will be informed to perform the same task as before 100 times, with the random possibility of seeing either a green or red light signal appear on each trial. When the light signal is red, participants will receive a painful electric shock via the electrode on Erb's point with a 10% probability for each trial (triggered by lifting the finger from the sensor), with at least one painful electric shock guaranteed during this session. When the light signal is green, participants are assured not to receive a painful electric shock. In this session, 30 TS and 30 doublets of SC+TS stimuli will be delivered randomly, using the customized ISI for each participant. The TS will be delivered at an intensity to evoke an MEP of 1mV, and the SC will be delivered at an intensity of 90% of the RMT, with single pulses or doublets of stimulation spaced at an interval varying between 8 and 12 seconds. In the future, there will not be 100 trials, but 60 trials, and no painful stimulus will be delivered. The objective will be solely to induce kinesiophobia when the red light appears to assess its influence on PPC-M1 connectivity between the "afraid to move" situation and the threat-free situation. The number of trials will be deliberately inflated to keep the participants alert and prevent them from assuming that they will reach the end of the session without experiencing any painful electric shock. Following the acquisition of TMS measurements, investigators will reveal the real objective of the study, emphasizing the need to induce a fear of movement using the red-light stratagem, which falsely indicates the probability of receiving a painful electric shock. After this revelation, the experimenter will ask each participant to rate their confidence in the diagnosis (how credible the threat of receiving a painful electric shock is) as well as the fear generated by the possibility of experiencing a painful electric shock, whether it results in injury or not. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06125613
Study type Interventional
Source Universite du Littoral Cote d'Opale
Contact
Status Completed
Phase N/A
Start date December 10, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Recruiting NCT06350084 - Effect of Mother's Touch and Nurse's Therapeutic Touch on Pain Level and Crying Time During Heel Blood Collection N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05458037 - RCT of Pain Perception With Fast and Slow Tenaculum Application N/A
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Recruiting NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Recruiting NCT05383820 - Effect of Paracetamol and Ketorolac on RANK-L Levels in Patients Starting Orthodontic Treatment Phase 4
Completed NCT04851353 - Multiple Sensory Interventions On Infants' Pain and Physiological Distress During Neonatal Screening Procedures N/A
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Not yet recruiting NCT04523623 - Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries N/A
Not yet recruiting NCT04491630 - COping With PAin Through Hypnosis, Mindfulness and Spirituality N/A
Not yet recruiting NCT04062513 - Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response N/A
Withdrawn NCT03137030 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults Phase 1
Withdrawn NCT03137017 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults Phase 1
Completed NCT04659395 - How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block N/A
Recruiting NCT03257319 - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department Phase 3